The results were consistent: Trunk fat reduction: Tesamorelin-treated patients showed statistically significant reductions in trunk fat versus placebo at 26 weeks.[1] VAT reduction: Using cross-sectional CT imaging, tesamorelin produced approximately 1520% reductions in visceral adipose tissue compared to placebo.[1,2] Triglyceride improvement: Alongside fat reduction, tesamorelin improved triglyceride levels a key marker in metabolic syndrome.[2] Tesamorelin IGF-1 elevation: Treatment reliably elevated IGF-1 levels toward age-appropriate norms, confirming successful GH-axis stimulation.[1] These reductions occurred without dietary caloric restriction being mandated
Placental microRNAs in pregnancies with early onset intrauterine growth restriction and preeclampsia: potential impact on gene expression and pathophysiology
By integrating B12 shots into their health regimen, they can ensure they are meeting their nutritional needs without compromising their dietary choices
BPC-157 and Tissue Support One of the most talked-about peptides in this space is BPC-157, which was originally derived from stomach tissue
If you have a medical condition, are on medication or are pregnant or nursing, please seek the advice of a qualified health care professional before using
